Tweet
Share
E-mailPotbotics Inc., operating as RYAH Group, has announced that, in connection with its business combination with Prime Blockchain Inc., the company, or resulting issuer from the transaction, has received conditional approval to list on the Canadian Securities Exchange (“CSE”). That approval is subject to completion of customary listing requirements outlined by the CSE, including receipt of all required documentation. The transaction, as previously announced, is a three-cornered merger between Potbotics, Prime, and RYAH Acquisition Corp., a wholly owned subsidiary of Prime incorporated for the purposes of completing the transaction, which will be conducted under the laws of the state of Florida. According to the announcement, the resulting company, RYAH Group, will combine its corporate existence with Subco, with the resulting entity becoming a wholly owned subsidiary of the resulting issuer. The company anticipated the transaction will be completed on or before April 19, 2021, assuming all closing conditions are met. At that point, RYAH Group will be approved to trade on the CSE using the ticker symbol RYAH.
To view the full press release, visit https://ibn.fm/5LIaL
About RYAH Group Inc.
RYAH is a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry. The company manages a complete digital ecosystem leveraging both Internet of Things (“IoT”) and artificial intelligence to create a dynamic data service for the medical plant industry. It is developing a suite of IoT devices, including a Smart-Patch and Smart-Inhaler device capable of storing all formulation lab results, measuring patient sessions in real time and capturing instant feedback for plant dose management. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant medical data, which is intended to help doctors and patients personalize plant-based and other therapeutic treatments to better predict treatment outcomes. The data collection is also relevant for pharmacies, clinics, growers, dispensaries and licensed processors (“LPs”) to monitor and manage plant-based medicine and other formulation effects on patients. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete medical plant life cycle, from seed to consumption. For more information about the company, please visit www.RyahGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
